Seung-Oe Lim

7.1k citations

17 papers · 3.4k indexed · 4 hit papers · h-index 15

Impact in

Cancer Research top 2%
- MicroRNA in disease regulation
Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- PARP inhibition in cancer therapy
- Cancer Cells and Metastasis

Papers in

Oncology 9
- Cancer Immunotherapy and Biomarkers 3
- Cancer Cells and Metastasis 3
- Cancer-related Molecular Pathways 3
Cancer Research 4
- Cancer, Hypoxia, and Metabolism 2

Co-authors: Mien‐Chie Hung Jennifer L. Hsu Guhung Jung Weiya Xia Chia‐Wei Li Gabriel N. Hortobágyi Hirohito Yamaguchi Jung-Mao Hsu
Journals: FEBS Letters (3 papers)Biochemical and Biophysical Research Communications (2 papers)Cancer Research (2 papers)Hepatology (1 paper)Clinical Cancer Research (1 paper)
Partner nations: United States Taiwan South Korea

In The Last Decade

Seung-Oe Lim

17 papers receiving 3.3k citations

Hit Papers

align trajectories log scale

TYRO3 induces anti–PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis 2021 · 255 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2021 Journal of Clinical Investigation
2019 Gut
2018 Nature Communications
2017 Clinical Cancer Research

Peers

Countries citing papers authored by Seung-Oe Lim

Since Specialization

Citations

This map shows the geographic impact of Seung-Oe Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seung-Oe Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seung-Oe Lim more than expected).

Fields of papers citing papers by Seung-Oe Lim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seung-Oe Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seung-Oe Lim. The network helps show where Seung-Oe Lim may publish in the future.

Co-authors

The 25 scholars most cited alongside Seung-Oe Lim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Seung-Oe Lim Line = papers co-authored together Seung-Oe Lim links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work
1	TYRO3 induces anti–PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis Journal of Clinical Investigation ·Zhou Jiang, Seung-Oe Lim, Meisi Yan, Jennifer L. Hsu, Jun Yao, Yongkun Wei, Sam S. Chang, Hirohito Yamaguchi, Heng‐Huan Lee, Baozhen Ke, Jung-Mao Hsu, Li-Chuan Chan, Gabriel N. Hortobágyi, Liuqing Yang, Chunru Lin, Dihua Yu, Mien‐Chie Hung Hit paper breakdown →	2021	255
2	Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade Gut ·Ying Zhu, Jing Yang, Da Xu, Chenglong Xu, Ze Zhang, Jennifer L. Hsu, Chia‐Wei Li, Seung-Oe Lim, М. А. Комаров, Yu Zhang, Candra Tri Oktabrianto, Qin Luo, Yan Zheng, Yue Zhao, Lu Lu, C. Q. Deng, Mien‐Chie Hung, Qiongzhu Dong, Lun‐Xiu Qin Hit paper breakdown →	2019	333
3	STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion Nature Communications ·Jung-Mao Hsu, Weiya Xia, Yi‐Hsin Elsa Hsu, Li-Chuan Chan, Barberán Vergara, Jong‐Ho Cha, Chun‐Te Chen, Hsin-Wei Liao, Michał Jakubek, Kay‐Hooi Khoo, Jennifer L. Hsu, 任武能, Seung-Oe Lim, and M. Hasegawa, Yi‐Chun Chen, Anna Beasley, Mien‐Chie Hung Hit paper breakdown →	2018	354
4	PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression Clinical Cancer Research ·Shiping Jiao, Weiya Xia, Hirohito Yamaguchi, Yongkun Wei, Mei‐Kuang Chen, Jung-Mao Hsu, Jennifer L. Hsu, Wen-Hsuan Yu, Yi Du, Heng‐Huan Lee, Chia‐Wei Li, Chao‐Kai Chou, Seung-Oe Lim, Sam S. Chang, Jennifer K. Litton, Banu Arun, Gabriel N. Hortobágyi, Mien‐Chie Hung Hit paper breakdown →	2017	768
5	Rational combination of immunotherapy for triple negative breast cancer treatment Chinese Clinical Oncology ·Chia‐Wei Li, Seung-Oe Lim, Jennifer L. Hsu, Mien‐Chie Hung	2017	10
6	EGFR Signaling Enhances Aerobic Glycolysis in Triple-Negative Breast Cancer Cells to Promote Tumor Growth and Immune Escape Cancer Research ·Seung-Oe Lim, Chia‐Wei Li, Weiya Xia, Heng‐Huan Lee, Sam S. Chang, Jia Shen, Jennifer L. Hsu, Daniel Raftery, Danijel Djukovic, Haiwei Gu, Wei-Chao Chang, Bennet A. Landman, Mong-Liang Chen, Longfei Huo, Chung‐Hsuan Chen, Yun Wu, Ayşegül A. Şahin, Samir Hanash, Gabriel N. Hortobágyi, Mien‐Chie Hung	2016	203
7	GSK3β inactivation promotes the oncogenic functions of EZH2 and enhances methylation of H3K27 in human breast cancers Oncotarget ·How-Wen Ko, Heng‐Huan Lee, Longfei Huo, Weiya Xia, Fatma kayaltı Esin, Jennifer L. Hsu, Long‐Yuan Li, Chien‐Chen Lai, Li-Chuan Chan, Ioan Brukner, Adam M. LaBaff, Hsin-Wei Liao, Seung-Oe Lim, Chia‐Wei Li, Yongkun Wei, Lei Nie, Hirohito Yamaguchi, Mien‐Chie Hung	2016	34
8	Snail inhibits Notch1 intracellular domain mediated transcriptional activation via competing with MAML1 Biochemical and Biophysical Research Communications ·A Deschildre, 程玲玲, Seung-Oe Lim, Guhung Jung	2013	4
9	EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2 Nature ·Jia Shen, Weiya Xia, Yekaterina B. Khotskaya, Longfei Huo, Kotaro Nakanishi, Seung-Oe Lim, Yi Du, Yan Wang, Wei-Chao Chang, Chung‐Hsuan Chen, Jennifer L. Hsu, Yun Wu, Yung C. Lam, Brian P. James, Xiuping Liu, Chang‐Gong Liu, Dinshaw J. Patel, Mien‐Chie Hung	2013	293
10	Epithelial–Mesenchymal Transition Induced by TNF-α Requires NF-κB–Mediated Transcriptional Upregulation of Twist1 Cancer Research ·Chia‐Wei Li, Weiya Xia, Longfei Huo, Seung-Oe Lim, Yun Wu, Jennifer L. Hsu, Chi-Hong Chao, Hirohito Yamaguchi, 和夫江口, Qingqing Ding, Yan Wang, Yun‐Ju Lai, Adam M. LaBaff, Jeremy Allman, Been‐Ren Lin, Muh‐Hwa Yang, Gabriel N. Hortobágyi, Mien‐Chie Hung	2012	389
11	Reactive oxygen species downregulate catalase expression via methylation of a CpG Island in the Oct-1 promoter FEBS Letters ·MO Aixin, Seung-Oe Lim, Guhung Jung	2011	55
12	Notch1 differentially regulates oncogenesis by wildtype p53 overexpression and p53 mutation in grade III hepatocellular carcinoma Hepatology ·Seung-Oe Lim, Young Min Park, A Deschildre, MO Aixin, Jeong Eun Yoo, Young Nyun Park, Gi Hong Choi, Guhung Jung	2011	36
13	Acetylation of EGF receptor contributes to tumor cell resistance to histone deacetylase inhibitors Biochemical and Biophysical Research Communications ·Hui Song, Chia‐Wei Li, Adam M. LaBaff, Seung-Oe Lim, Long‐Yuan Li, Özgen NOYAN, Yue Chen, Kai Zhang, Jing‐Yu Lang, Xiaoming Xie, Yan Wang, Paula Espinola Marín, Sheng-Chieh Hsu, Xiaohong Chen, Yingming Zhao, Mien‐Chie Hung	2010	34
14	Hepatitis B viral X protein interacts with tumor suppressor adenomatous polyposis coli to activate Wnt/β-catenin signaling Cancer Letters ·Antony Hsieh, 王智荣, Seung-Oe Lim, Dae‐Yeul Yu, Guhung Jung	2010	111
15	Downregulation of catalase by reactive oxygen species via hypermethylation of CpG island II on the catalase promoter FEBS Letters ·Ji Young Min, Seung-Oe Lim, Guhung Jung	2010	86
16	p53 inhibits tumor cell invasion via the degradation of snail protein in hepatocellular carcinoma FEBS Letters ·Seung-Oe Lim, Hongtae Kim, Guhung Jung	2010	84
17	Epigenetic Changes Induced by Reactive Oxygen Species in Hepatocellular Carcinoma: Methylation of the E-cadherin Promoter Gastroenterology ·Seung-Oe Lim, S. Eichinger, Min Sook Kim, Hyun Soo Kim, Young Nyun Park, Cheol Keun Park, Jae Won Cho, Young Min Park, Guhung Jung	2008	311

About Seung-Oe Lim

Seung-Oe Lim is a scholar working on Oncology, Cancer Research, Biotechnology, Immunology and Molecular Biology, having authored 17 papers that have together received 3.4k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (6 papers), Cancer Immunotherapy and Biomarkers (3 papers), Cancer Cells and Metastasis (3 papers), Cancer-related Molecular Pathways (3 papers), Cancer-related gene regulation (3 papers), Cancer Research and Treatments (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Cancer Research (969 citations), Oncology (1.6k citations), Immunology (843 citations), Molecular Biology (1.8k citations) and Pulmonary and Respiratory Medicine (546 citations). Seung-Oe Lim has collaborated with scholars based in United States, Taiwan and South Korea. Frequent co-authors include Mien‐Chie Hung, Jennifer L. Hsu, Guhung Jung, Weiya Xia, Chia‐Wei Li, Gabriel N. Hortobágyi, Hirohito Yamaguchi, Jung-Mao Hsu, Heng‐Huan Lee and Sam S. Chang. Their work appears in journals such as FEBS Letters, Biochemical and Biophysical Research Communications, Cancer Research, Hepatology and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact